Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack M Sullivan

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Experimental Eye Research|March 25, 2009
Focus on molecules: ABCA4 (ABCR)--an import-directed photoreceptor retinoid flipaseJack M Sullivan
Molecular Therapy. Nucleic Acids|March 4, 2025
Enhanced hammerhead ribozyme turnover rates: Reevaluating therapeutic space for small catalytic RNAsJason M Myers, Jack M Sullivan
Investigative Ophthalmology & Visual Science|November 10, 2015
A Novel, Real-Time, In Vivo Mouse Retinal Imaging SystemMark C Butler, Jack M Sullivan
Experimental Eye Research|January 25, 2011
Rapid, cell-based toxicity screen of potentially therapeutic post-transcriptional gene silencing agentsTiffany A Kolniak, Jack M Sullivan
Journal of Visualized Experiments : Jove|November 20, 2018
Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy ResearchMark C Butler, Jack M Sullivan
The Journal of General Physiology|May 30, 2002
HEK293S cells have functional retinoid processing machineryLioubov I Brueggemann, Jack M Sullivan
Experimental Eye Research|May 29, 2016
A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targetsEdwin H Yau, Mark C Butler, Jack M Sullivan
Investigative Ophthalmology & Visual Science|October 17, 2009
A high-throughput biophotonics instrument to screen for novel ocular photosensitizing therapeutic agentsMark C Butler, Patrick N Itotia, Jack M Sullivan
Investigative Ophthalmology & Visual Science|July 18, 2017
Effects of Pathogenic Variations in the Human Rhodopsin Gene (hRHO) on the Predicted Accessibility for a Lead Candidate RibozymeBeau R Froebel, Alexandria J Trujillo, Jack M Sullivan
Ophthalmic Genetics|January 15, 2024
<i>RTN4IP1</i>-associated non-syndromic optic neuropathy and rod-cone dystrophyPriya R Gupta, Kaitlin O'Connell, Jack M Sullivan, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Experimental Eye Research|March 25, 2009
Focus on molecules: ABCA4 (ABCR)--an import-directed photoreceptor retinoid flipaseJack M Sullivan
Molecular Therapy. Nucleic Acids|March 4, 2025
Enhanced hammerhead ribozyme turnover rates: Reevaluating therapeutic space for small catalytic RNAsJason M Myers, Jack M Sullivan
Investigative Ophthalmology & Visual Science|November 10, 2015
A Novel, Real-Time, In Vivo Mouse Retinal Imaging SystemMark C Butler, Jack M Sullivan
Experimental Eye Research|January 25, 2011
Rapid, cell-based toxicity screen of potentially therapeutic post-transcriptional gene silencing agentsTiffany A Kolniak, Jack M Sullivan
Journal of Visualized Experiments : Jove|November 20, 2018
Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy ResearchMark C Butler, Jack M Sullivan
The Journal of General Physiology|May 30, 2002
HEK293S cells have functional retinoid processing machineryLioubov I Brueggemann, Jack M Sullivan
Experimental Eye Research|May 29, 2016
A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targetsEdwin H Yau, Mark C Butler, Jack M Sullivan
Investigative Ophthalmology & Visual Science|October 17, 2009
A high-throughput biophotonics instrument to screen for novel ocular photosensitizing therapeutic agentsMark C Butler, Patrick N Itotia, Jack M Sullivan
Investigative Ophthalmology & Visual Science|July 18, 2017
Effects of Pathogenic Variations in the Human Rhodopsin Gene (hRHO) on the Predicted Accessibility for a Lead Candidate RibozymeBeau R Froebel, Alexandria J Trujillo, Jack M Sullivan
Ophthalmic Genetics|January 15, 2024
<i>RTN4IP1</i>-associated non-syndromic optic neuropathy and rod-cone dystrophyPriya R Gupta, Kaitlin O'Connell, Jack M Sullivan, et al.
Pageof 3